Article · Volume 14, Issue 2 · pp. 426–433
Molecular Docking Studies: Hepatitis C Viral-RNA-Dependent RNA Polymerase (RdRp) Inhibitory Activity of Siddha Herbal Formulation Sittramutti khirutham (SK)
Medini Elanchezhian1, Suresh Ramasamy2, Abarna Balasubramani3, Lakshmanaraj Chidambaram1
- 1Department of Siddhar Yoga Maruthuvam, Government Siddha Medical College, Chennai, Tamil Nadu, INDIA.
- 2Department of Gunapadam, National Institute Siddha, Chennai, Tamil Nadu, INDIA.
- 3Department of Nanju Maruthuvam, National Institute Siddha, Chennai, Tamil Nadu, INDIA.
Abstract
Background: Docking studies of Sittramutti khirutham (SK) compounds against HCV RdRp (PDB:3MWV) were performed to evaluate inhibitory potential.Results: Compounds such as Curcumin, Maslinic acid, Arjungenin, Andrograpanin, Andrographolide, and Epiafzelechin showed 2–3 interactions with active residues, indicating promising RdRp inhibition.Conclusion: Docking suggests SK compounds may inhibit HCV RdRp and warrant further pharmacological validation.
Keywords: Hepatitis C; Molecular docking; Siddha
The full text of this article is available as a PDF. Open the PDF.
